No­var­tis to shut­ter NC-based San­doz plant ahead of spin­off

As San­doz is ready to spin out from No­var­tis, the par­ent com­pa­ny is shut­ter­ing an oral sol­id dosage plant in Wil­son, North Car­oli­na.

The plant, which makes tablets and cap­sules for Cana­da and the US, em­ploys about 246 peo­ple who have al­ready been alert­ed to the clo­sure, a No­var­tis spokesper­son told sev­er­al me­dia out­lets. But most of the em­ploy­ees are like­ly to be let go, un­less there is a “late sale of the site” to a buy­er in­ter­est­ed in re­tain­ing staff, a spokesper­son said.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.